Hikma Pharmaceuticals Investor Relations Material
Latest events
Trading Update
Hikma Pharmaceuticals
Access the full event backlog
Slides, Transcripts, and Reports from 11,000+ public companies
Latest reports from Hikma Pharmaceuticals PLC
Access all reports
Hikma Pharmaceuticals PLC develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products. The company's non-specialty portfolio includes drugs treating diabetes, heart disease, pain management, respiratory disease and other disorders for adults as well as children. The company operates as a regional pharmaceutical company that develops, manufactures, markets and sells a range of generic, branded and its in-licensed products from pain management to oncology.
Key slides for Hikma Pharmaceuticals PLC
43rd Annual J.P. Morgan Healthcare Conference 2025
Hikma Pharmaceuticals PLC
43rd Annual J.P. Morgan Healthcare Conference 2025
Hikma Pharmaceuticals PLC
Latest articles
Mercado Libre: The Digital Backbone of Latin America
From shopping to logistics and fintech, Mercado Libre is shaping the digital transformation of Latin America.
3 Jan 2025
House of Pinault: The History and Business of Kering and Gucci
Kering is a luxury group under the Pinault family's leadership, managing iconic brands like Gucci, Saint Laurent, and Bottega Veneta.
19 Dec 2024
Under the Hood: AutoZone's Blueprint for Retail Excellence
An in-depth look at the largest aftermarket auto parts retailer in the U.S., its philosophy, and masterful capital allocation.
19 Dec 2024
Ticker symbol
HIK
Country
🇬🇧 United Kingdom